Prodesse Inc. of Waukesha, Wis., and
Invitrogen Corp. of Carlsbad, Calif., have signed a licensing agreement for diagnostic
assays that incorporate the latter company’s Lux technology, reagents used
in gene expression studies, biomarker analysis and functional genomics experiments.
The arrangement will use Prodesse’s distribution capabilities to bring the
technology to new market segments.
MORE FROM PHOTONICS MEDIA